Skip to main content

product_launch

Duck Creek Claims Wins Luminary Rating, Two XCelent Awards from Celent

Image
Duck Creek Claims Wins Luminary Rating, Two XCelent Awards from Celent

Boston – September 13, 2026 -- Duck Creek has secured a Luminary rating, the highest possible score in Celent's Technical Capabilities Matrix, along with two XCelent Awards for Advanced Technology and Breadth of Functionality in the research firm's 2026 Claims Systems Vendors: North America P&C Insurance report.

Celent names Duck Creek Claims a top performer for third consecutive year

The recognition marks the third consecutive time Duck Creek has received Celent honors for its claims solution. Celent evaluated vendors on functionality, technology architecture, and customer base and support, reserving the Luminary distinction for the strongest performers across both technical criteria.

Qualtrics Unveils XM Data & AI Platform, Cites $3T Experience Gap

Image
Qualtrics Unveils XM Data & AI Platform, Cites $3T Experience Gap

Provo, Utah – September 13, 2026 -- Qualtrics has introduced its XM Data & AI Platform, a system designed to close what the company calls the "Experience Gap" -- a divide between customer expectations and delivery that it estimates puts close to $3 trillion in sales at risk globally.

Qualtrics builds new platform on data from 18,000 organizations and 41,000 healthcare facilities

The platform consolidates more than two decades of Qualtrics experience data across 18,000 organizations with four decades of healthcare experience data from Press Ganey, spanning over 41,000 facilities. Qualtrics acquired Press Ganey Forsta in May 2026 for $6.75 billion, a deal the company says added regulatory-grade governance and anonymized health data to its experience dataset.

BLAZE Launches Headless E-Commerce API for Cannabis Retailers

Image
BLAZE Launches Headless E-Commerce API for Cannabis Retailers

Los Angeles – September 13, 2026 -- BLAZE has launched the BLAZE E-Commerce API, a headless commerce solution giving licensed cannabis dispensaries and multi-state operators full creative and technical control over their online storefronts while retaining compliance, inventory, and payment infrastructure required in regulated retail.

API grants developers full access to product, cart, order, and compliance data

The BLAZE E-Commerce API allows teams to build fully custom websites or in-store kiosks. It connects natively with BLAZE Retail POS, syncing inventory, pricing, and order data between a dispensary's physical and digital storefronts with minimal maintenance.

Sceye's ST1 Completes 30,000km Stratospheric Flight With SoftBank

Image
Sceye's ST1 Completes 30,000km Stratospheric Flight With SoftBank

Moriarty, New Mexico – September 13, 2026 -- Sceye's ST1 high-altitude platform completed a nearly 30,000 km round-trip flight from New Mexico to Japan and back, re-entering continental U.S. airspace on September 4, 2026 and reaching Moriarty, New Mexico on September 5, 2026, where the company conducted final vehicle testing and a planned descent.

ST1 marks Sceye's first flight to Asia in partnership with SoftBank

The month-long mission was conducted with SoftBank Corp. (TOKYO: 9434) and represents Sceye's first flight into Asian airspace. ST1 carried SceyeCELL, described as a first-of-its-kind stratospheric "cell tower in the sky" built to deliver wide-area mobile broadband directly to standard devices. At full scale, one Sceye HAPS is designed to cover an area equivalent to roughly 500 terrestrial towers.

Sceye's ST1 Stratospheric Platform Completes 30,000km Japan-US Round Trip

Image
Sceye's ST1 Stratospheric Platform Completes 30,000km Japan-US Round Trip

Moriarty, New Mexico – September 13, 2026 -- Sceye's ST1 high-altitude platform station has completed a nearly 30,000-kilometer round trip between New Mexico and Japan, re-entering the continental United States on September 4, 2026, and reaching the company's Moriarty headquarters airspace on September 5 for final tests and controlled descent.

ST1 marks Sceye's first flight into Asian airspace under a SoftBank partnership

The month-long mission, conducted with Japanese telecom operator SoftBank Corp. (TOKYO: 9434), represents a commercial milestone for high-altitude platform station (HAPS) deployment. ST1 operated in Japanese airspace for more than seven days, maintaining continuous position over Japan's coast with a station-keeping radius of just 5 kilometers at altitudes between 16.5 and 17 km.

Acqualina Resort Relaunches Website With Digital Silk to Boost Bookings

Miami – September 13, 2026 -- Acqualina Resort & Residences, a Forbes Five-Star, AAA Five Diamond property named USA Today's "No. 1 Best Destination Resort" for the sixth time in 2026, has relaunched its website in partnership with Miami-based agency Digital Silk.

Digital Silk rebuilt Acqualina's site around four business priorities: revenue, brand awareness, credibility and guest loyalty.

The redesign followed a full audit of positioning, audiences and business goals, producing a new brand book, style guide and custom CMS. The final build integrates a booking engine, interactive maps, event calendars and a live beach camera, with distinct navigation paths for accommodations, dining, spa and events.

Nauticus Robotics Launches ToolKITT Autonomy Suite for ROV Retrofits

Image
Nauticus Robotics Launches ToolKITT Autonomy Suite for ROV Retrofits

Houston – September 13, 2026 -- Nauticus Robotics, Inc. (NASDAQ: KITT) has commercially released Nauticus ToolKITT, a licensed autonomy software suite that retrofits onto remotely operated vehicles (ROVs) already deployed on live subsea projects, the company confirmed during its most recent earnings call.

Software cuts pilot workload without replacing existing ROV fleets

Nauticus ToolKITT is offered with a Pilot Assist module designed to hold vehicles steady, compensate for currents, and support waypoint navigation while the pilot retains full operational supervision. The system integrates with a vehicle manufacturer's existing OEM control software rather than replacing it, allowing operators to add autonomous functions without purchasing new vehicles.

Hyper3D Launches WorldGen to Turn Photos Into 3D Simulation Scenes

Image
Hyper3D Launches WorldGen to Turn Photos Into 3D Simulation Scenes

Los Angeles – September 13, 2026 -- Hyper3D has launched WorldGen, a world-generation model that converts a single image into a 3D scene made up of independent, editable objects, extending the company's generative 3D technology beyond single-object creation into full scene reconstruction for robotics, filmmaking and game development.

Brennan Breaks Ground on 210,000 SF Nashville Industrial Project

Whites Creek, Tennessee – September 13, 2026 -- Brennan Investment Group has commenced construction on a 210,000 square-foot, Class A speculative industrial facility on 17 acres in Whites Creek, Tennessee, with completion targeted for the second quarter of 2027.

Site sits eight miles from downtown Nashville with direct interstate access

The property is located less than a half-mile from the Interstate 24 interchange at Old Hickory Boulevard, giving future occupiers access to Nashville's three major interstates. Andrew Mazey, Brennan's Senior Vice President for the Nashville and Atlanta regions, said the location will draw last-mile and regional distribution users, and sits a 30-minute drive from Clarksville, Tennessee, a fast-growing manufacturing market.

Kazia Doses First Patient in Pediatric Brain Cancer Study

Image
Kazia Doses First Patient in Pediatric Brain Cancer Study

Sydney – September 13, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has dosed the first patient in Arm A of PNOC035, a Phase 2 platform study testing paxalisib combined with gemcitabine for recurrent or progressive atypical teratoid/rhabdoid tumor (AT/RT), an aggressive pediatric brain cancer with no approved therapies.

Preclinical data showed the combination nearly quadrupled median survival in an AT/RT model

In an orthotopic AT/RT preclinical model, the paxalisib-gemcitabine combination extended median survival from 22 to 82.5 days (p0.0001) and showed complementary anti-tumor activity across multiple AT/RT cell lines. These findings, previously presented at ISPNO, AACR and Neuro-Oncology meetings, formed the scientific basis for advancing into the multicenter PNOC035 trial.